Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

I also found this interesting:

"In particular, early dialogue and timely preparation for
conditional applications could support prompt assessment and generation of the required post-authorisation data, and further efforts could target those therapeutic areas that so far have
not been successful in applying this regulatory tool."

I believe we've had quite a bit of early dialogue.